Ratings for Globus Medical (NYSE:GMED) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 4 | 0 | 1 | 0 |
| Last 30D | 0 | 3 | 0 | 1 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $85.0, a high estimate of $100.00, and a low estimate of $77.00. This current average has increased by 13.77% from the previous average price target of $74.71.
Analyzing Analyst Ratings: A Detailed Breakdown
An in-depth analysis of recent analyst actions...
Login or create a forever free account to read this news
Sign up/Log in
